| Product Code: ETC066994 | Publication Date: Aug 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Non-Oncology Precision Medicine Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Poland Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Poland Non-Oncology Precision Medicine Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 Poland Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 Poland Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing demand for personalized treatments in non-oncology diseases |
4.2.2 Increasing adoption of advanced genetic testing technologies |
4.2.3 Government initiatives to promote precision medicine in Poland |
4.3 Market Restraints |
4.3.1 High costs associated with precision medicine treatments |
4.3.2 Limited awareness and understanding of precision medicine among healthcare professionals and patients |
5 Poland Non-Oncology Precision Medicine Market Trends |
6 Poland Non-Oncology Precision Medicine Market, By Types |
6.1 Poland Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2027F |
6.1.3 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2027F |
6.1.4 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2027F |
6.1.5 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2027F |
6.1.6 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.1.7 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 Poland Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2027F |
6.2.3 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2027F |
6.2.4 Poland Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2027F |
7 Poland Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Poland Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Poland Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Poland Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering non-oncology precision medicine services in Poland |
8.2 Percentage increase in research and development investment in non-oncology precision medicine |
8.3 Number of healthcare professionals trained in precision medicine techniques for non-oncology diseases |
9 Poland Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Poland Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Poland Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 Poland Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Poland Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2021 |
10.2 Poland Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here